Direct activation of STING in the tumor microenvironment with synthetic cyclic dinucleotide derivatives leads to potent and systemic tumor-specific immunity

nork Corrales, Leticia, Glickman, Laura Hix, McWhirter, Sarah M, Kanne, David B, Sivick, Kelsey E, Lemmens, Edward, Leong, Justin J, Metchette, Ken, Dubensky, Thomas W, Gajewski, Thomas
Argitaratua izan da J Immunother Cancer (2014)

Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity

nork Corrales, Leticia, Glickman, Laura Hix, McWhirter, Sarah M., Kanne, David B., Sivick, Kelsey E., Katibah, George E., Woo, Seng-Ryong, Lemmens, Edward, Banda, Tamara, Leong, Justin J., Metchette, Ken, Dubensky, Thomas W., Gajewski, Thomas F.
Argitaratua izan da Cell Rep (2015)

STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade

nork Fu, Juan, Kanne, David B., Leong, Meredith, Glickman, Laura Hix, McWhirter, Sarah M., Lemmens, Edward, Mechette, Ken, Leong, Justin J., Lauer, Peter, Liu, Weiqun, Sivick, Kelsey E., Zeng, Qi, Soares, Kevin C., Zheng, Lei, Portnoy, Daniel A., Woodward, Joshua J., Pardoll, Drew M., Dubensky, Thomas W., Kim, Young
Argitaratua izan da Sci Transl Med (2015)

STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection

nork Van Dis, Erik, Sogi, Kimberly M., Rae, Chris S., Sivick, Kelsey E., Surh, Natalie H., Leong, Meredith L., Kanne, David B., Metchette, Ken, Leong, Justin J., Bruml, Jacob R., Chen, Vivian, Heydari, Kartoosh, Cadieux, Nathalie, Evans, Tom, McWhirter, Sarah M., Dubensky, Thomas W., Portnoy, Daniel A., Stanley, Sarah A.
Argitaratua izan da Cell Rep (2018)